Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Beginning Cash Balance (2021 - 2023)

Historic Beginning Cash Balance for Bioadaptives (BDPT) over the last 3 years, with Q3 2023 value amounting to $50000.0.

  • Bioadaptives' Beginning Cash Balance changed N/A to $50000.0 in Q3 2023 from the same period last year, while for Dec 2024 it was $50000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $50000.0 for FY2023, which is 298071.47% up from last year.
  • As of Q3 2023, Bioadaptives' Beginning Cash Balance stood at $50000.0.
  • In the past 5 years, Bioadaptives' Beginning Cash Balance registered a high of $50000.0 during Q3 2023, and its lowest value of $1623.0 during Q1 2021.
  • Over the past 3 years, Bioadaptives' median Beginning Cash Balance value was $1623.0 (recorded in 2021), while the average stood at $17748.7.
  • Data for Bioadaptives' Beginning Cash Balance shows a peak YoY increase of 0.0% (in 2022) and a maximum YoY decrease of 0.0% (in 2022) over the last 5 years.
  • Bioadaptives' Beginning Cash Balance (Quarter) stood at $1623.0 in 2021, then changed by 0.0% to $1623.0 in 2022, then surged by 2980.71% to $50000.0 in 2023.
  • Its last three reported values are $50000.0 in Q3 2023, $1623.0 for Q1 2022, and $1623.0 during Q1 2021.